-
公开(公告)号:WO2014078373A1
公开(公告)日:2014-05-22
申请号:PCT/US2013/069828
申请日:2013-11-13
申请人: IOGENETICS, LLC
IPC分类号: C07K16/46 , C12N15/13 , A61K39/395
CPC分类号: C07K16/1271 , C07K2317/56 , C07K2319/33 , C12N9/52 , C12Y304/24075
摘要: The present invention relates antimicrobial compositions, and in particular to antigen binding proteins comprising one or more domains that provide antimicrobial activity.
摘要翻译: 本发明涉及抗微生物组合物,特别涉及包含提供抗微生物活性的一个或多个结构域的抗原结合蛋白。
-
公开(公告)号:WO2017132210A1
公开(公告)日:2017-08-03
申请号:PCT/US2017/014852
申请日:2017-01-25
申请人: IOGENETICS, LLC
CPC分类号: A61K38/02 , A61K39/00 , A61K39/015 , A61K39/12 , C07K14/08 , C12N2770/24134 , C12N2770/36134 , Y02A50/383 , Y02A50/386 , Y02A50/388 , Y02A50/39 , Y02A50/392 , Y02A50/394 , Y02A50/396 , Y02A50/412
摘要: The present invention relates to vaccine compositions and therapeutic interventions for treating and preventing infections and diseases caused by flaviviruses, including Zika, dengue, and Usutu virus. It also relates to compositions and methods for diagnosis and differential diagnosis of flaviviruses and co-endemic pathogens.
摘要翻译: 本发明涉及用于治疗和预防由黄病毒引起的感染和疾病的疫苗组合物和治疗性干预,所述黄病毒包括Zika,登革热和Usutu病毒。 它还涉及黄病毒和共同流行病原体的诊断和鉴别诊断的组合物和方法。 p>
-
公开(公告)号:WO2016007870A2
公开(公告)日:2016-01-14
申请号:PCT/US2015/039969
申请日:2015-07-10
申请人: IOGENETICS, LLC
发明人: BREMEL, Robert D. , HOMAN, Jane , IMBODEN, Michael
IPC分类号: G06F19/20
CPC分类号: G06F19/22 , G01N33/6854 , G01N33/6878 , G01N2800/24 , G06F19/18 , G06F19/28
摘要: The present invention provides methods and systems for identifying and classifying epitopes and use of that information to analyze proteins and peptides within proteins, especially potential epitopes, and to use the information to design synthetic peptides and proteins, analyze biopharmaceutical proteins, and diagnose autoimmune conditions. Peptides which are bound in MHC grooves comprise two sets of amino acids: those that face inwards into the groove and determine the binding affinity to the MHC molecule (the groove exposed motifs or GEM) and those which do not interact with the groove but rather are on the obverse side exposed outwardly to the T-cells (the T-cell exposed Motifs or TCEM). The present invention utilizes information related to the identity and physiochemical characteristics of the GEM and TCEM.
摘要翻译: 本发明提供用于鉴定和分类表位的方法和系统,以及该信息的使用以分析蛋白质,特别是潜在表位内的蛋白质和肽,并使用该信息来设计合成肽和蛋白质,分析生物药物蛋白质并诊断自身免疫病症。 在MHC槽中结合的肽包含两组氨基酸:那些面向内槽并确定与MHC分子(凹槽暴露图案或GEM)的结合亲和力以及不与凹槽相互作用的那些氨基酸 在外侧暴露于T细胞(T细胞暴露的基序或TCEM)的正面上。 本发明利用与GEM和TCEM的身份和物理化学特性相关的信息。
-
公开(公告)号:WO2010083225A2
公开(公告)日:2010-07-22
申请号:PCT/US2010/020910
申请日:2010-01-13
申请人: IOGENETICS, LLC. , ARIZONA BOARD OF REGENTS on behalf of THE UNIVERSITY OF ARIZONA , IMBODEN, Michael , RIGGS, Michael , SCHAEFER, Deborah, A. , HOMAN, Jane
IPC分类号: A01N63/02 , A01N63/00 , A01P1/00 , A01P3/00 , A61K38/16 , C07K19/00 , C12N15/62 , C12N15/867
CPC分类号: C07K16/20 , A01K2217/052 , A01K2217/206 , A01K2227/101 , A01K2267/01 , A61K2039/505 , C07K2317/24 , C07K2317/76 , C07K2319/00 , C07K2319/01 , C07K2319/035 , C12N2740/13043 , Y02A50/488
摘要: The present invention relates to fusion proteins comprising a microorganism targeting molecule ( e.g. , immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
摘要翻译: 本发明涉及包含微生物靶向分子(例如,免疫球蛋白)和杀生物剂的融合蛋白。 本发明还涉及在不同领域使用包含微生物靶向分子和杀生物剂的融合蛋白的治疗性和预防性方法。 p>
-
公开(公告)号:WO2006132665A2
公开(公告)日:2006-12-14
申请号:PCT/US2005/037709
申请日:2005-10-19
IPC分类号: A61K38/47
CPC分类号: A61K38/465 , A01N63/02 , A23B4/20 , A23L3/3463 , A61K38/1729 , A61K38/40 , A61L2/18 , A61L2/23 , C02F1/50 , C02F2103/02
摘要: The present invention relates to the use of biocide (e.g., bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., water purification).
摘要翻译: 本发明涉及杀生物剂(例如杀菌酶)用于靶向病原体的用途。 特别地,本发明提供用于保健(例如人类和兽医),农业(例如动物和植物生产)和食品加工(例如水净化)中的杀生物剂。
-
公开(公告)号:WO2007047189A2
公开(公告)日:2007-04-26
申请号:PCT/US2006/039361
申请日:2006-10-10
CPC分类号: C07K16/14 , A61K2039/505 , C07K16/20 , C07K2317/12 , C07K2317/622 , C07K2317/76 , C07K2319/30 , C07K2319/55
摘要: The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule ( e.g., immunoglobulin or innate immune system receptor molecule) and a biocide ( e.g ., bactericidal enzyme) in transgenic animals ( e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care ( e.g ., human and veterinary), agriculture ( e.g., animal and plant production), and food processing ( e.g., beef carcass processing). The present invention also relates to methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in various diagnostic applications in number of diverse fields such as agriculture, medicine, and national defense.
摘要翻译: 本发明涉及编码新单克隆抗体,新型融合蛋白和嵌合单克隆抗体的逆转录病毒构建体及其使用和生产方法。 特别地,本发明涉及在转基因动物(例如牛)和细胞中产生包含微生物靶向分子(例如,免疫球蛋白或先天性免疫系统受体分子)和杀生物剂(例如,杀菌酶)的融合蛋白的方法 文化。 本发明还涉及在医疗保健(例如人类和兽医),农业(例如动物和植物生产)和食品加工(例如,动物和植物生产)中使用包含微生物靶向分子和杀生物剂的融合蛋白的治疗和预防方法, 牛肉屠体处理)。 本发明还涉及在农业,医药,国防等不同领域的多种诊断应用中使用包含微生物靶向分子和杀生物剂的融合蛋白的方法。
-
-
-
-
-